MedTrace Logo

Intraprostatic Injection of Tranexamic Acid Decrease Blood Loss During Monopolar TURP

NCT05913466 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-06-22

No results posted yet for this study

Summary

This study aims to assess the role of intraprostatic injection of tranexamic acid in decreasing the blood loss during Transurethral resection of the prostate.

Conditions

  • Benign Prostatic Hyperplasia
  • Transurethral Resection of the Prostate
  • Tranexamic Acid

Interventions

DRUG

Tranexamic Acid group

Patients in this group will receive 1 gm of Tranexamic Acid (Cyklokapron) that will be dissolved in 50 ml of injectable 0.9% saline

DRUG

Distilled water group

This group will receive 10 mL of distilled water (placebo) in 1 L of irrigation solution sterile wash (glycine).

Sponsors & Collaborators

  • Benha University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-20
Primary Completion
2024-06-20
Completion
2024-06-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05913466 on ClinicalTrials.gov